Smoking cessation and secondary stroke prevention
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The ≈7 million adult stroke survivors in the United States remain at high risk for a recurrent stroke. The increased morbidity and cost associated with recurrent stroke, in addition to the 5% to 20% yearly stroke recurrence, support the need for additional investigations into secondary stroke prevention.1,2 Stroke prevention guidelines, whether primary or secondary, focus on risk factor control of modifiable risk factors. The American Heart Association/American Stroke Association guidelines for secondary stroke prevention indicate evidence-based risk factor control, interventional approaches, and treatment options as approaches to secondary stroke prevention.1 Risk factor control for secondary stroke prevention includes managing hypertension, diabetes mellitus, and hyperlipidemia, as well as lifestyle modifications, including weight management, alcohol consumption, and smoking cessation.3 A cornerstone of recurrent stroke reduction, and lifetime cardiovascular disease (CVD) risk, is modification of lifestyle behaviors such as abstaining from tobacco, adopting a healthy diet, and exercising regularly. While these healthy lifestyle behaviors should start in childhood and continue through one's lifetime, modifying these health behaviors after a stroke can reduce the risk of recurrent stroke and other CVD-related illnesses.3
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the author, if any, are provided at the end of the editorial.
See page 1723
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Editorialist response to Prof. Munakomi
- Amelia Boehme, Assistant Professor, Columbia University
Submitted January 25, 2018 - Tobacco smoke free environment: A need of this hour
- Sunil Munakomi, Assistant Professor, Kathmandu Universitysunilmunakomi@gmail.com
Submitted September 19, 2017
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or strokeMarion Boulanger, Linxin Li, Shane Lyons et al.Neurology, July 23, 2019 -
Article
Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatalityKaren C. Albright, Lei Huang, Justin Blackburn et al.Neurology, October 03, 2018 -
Views & Reviews
Potential new uses of non–vitamin K antagonist oral anticoagulants to treat and prevent strokeShadi Yaghi, Hooman Kamel, Mitchell S.V. Elkind et al.Neurology, July 17, 2015 -
Article
Percutaneous patent foramen ovale closure for secondary stroke preventionNetwork meta-analysisGeorgios Tsivgoulis, Aristeidis H. Katsanos, Dimitris Mavridis et al.Neurology, June 06, 2018